CTX is a rare disease associated with xanthoma and multiple neurologic defects.
CTX is due to mutations in CYP27A1 leading to high cholestanol levels.
CTX can be a treated with chenodeoxycholic acid to lower cholestanol.
Early diagnosis and treatment of CTX is required to limit long-term morbidity.